0001104659-26-025331
SEC filingUnited Therapeutics Corporation filed an 8-K on March 9, 2026, disclosing that on March 8, 2026, its Board of Directors approved an action under Item 1.01 Entry into a Material Definitive Agreement. Item 7.01 includes Exhibit 99.1 press release dated March 9, 2026, furnished but not filed.